AJOVY 150 MG/ML SOL INJ CT SER PREENC VD TRANS X 1,5 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1557300500026 -
GGREM
537520050009007 -
Código de barras
7898587901369
O que a fonte publica
- Detentor do registro
- TEVA FARMACÊUTICA LTDA.
- Princípios ativos
- FREMANEZUMABE
- Embalagem
- 150 MG/ML SOL INJ CT SER PREENC VD TRANS X 1,5 ML
- Tipo de produto
- Biológico
- Classe terapêutica
- N2C2 - ANTAGONISTAS DA CGRP ANTI-ENXAQUECA
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "AJOVY 150 MG/ML SOL INJ CT SER PREENC VD TRANS X 1,5 ML",
"holder": "TEVA FARMACÊUTICA LTDA.",
"stripe": null,
"barcodes": [
"7898587901369"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "537520050009007",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "05.333.542/0001-08",
"priceRegime": "Regulado",
"productName": "AJOVY",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "150 MG/ML SOL INJ CT SER PREENC VD TRANS X 1,5 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "1991.25",
"icms-12": "2262.78",
"icms-17": "2399.10",
"icms-18": "2428.35",
"icms-19": "2458.33",
"icms-20": "2489.06",
"icms-21": "2520.57",
"icms-22": "2552.88",
"icms-23": "2586.04",
"icms-17.5": "2413.64",
"icms-19.5": "2473.60",
"icms-20.5": "2504.72",
"icms-22.5": "2569.36",
"icms-12-alc": "2020.34",
"icms-17-alc": "2142.05",
"icms-18-alc": "2168.17",
"icms-19-alc": "2194.94",
"icms-20-alc": "2222.38",
"icms-21-alc": "2250.51",
"icms-22-alc": "2279.36",
"icms-23-alc": "2308.96",
"withoutTaxes": "1777.90",
"icms-17.5-alc": "2155.03",
"icms-19.5-alc": "2208.57",
"icms-20.5-alc": "2236.35",
"icms-22.5-alc": "2294.07"
},
"pisCofinsList": "Negativa",
"substanceText": "FREMANEZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "2671.19",
"icms-12": "3035.44",
"icms-17": "3218.31",
"icms-18": "3257.55",
"icms-19": "3297.76",
"icms-20": "3338.99",
"icms-21": "3381.25",
"icms-22": "3424.60",
"icms-23": "3469.08",
"icms-17.5": "3237.81",
"icms-19.5": "3318.25",
"icms-20.5": "3359.99",
"icms-22.5": "3446.70",
"icms-12-alc": "2793.00",
"icms-17-alc": "2961.26",
"icms-18-alc": "2997.37",
"icms-19-alc": "3034.38",
"icms-20-alc": "3072.31",
"icms-21-alc": "3111.20",
"icms-22-alc": "3151.08",
"icms-23-alc": "3192.00",
"withoutTaxes": "2457.84",
"icms-17.5-alc": "2979.20",
"icms-19.5-alc": "3053.22",
"icms-20.5-alc": "3091.62",
"icms-22.5-alc": "3171.42"
},
"invalidBarcodes": [],
"activeSubstances": [
"FREMANEZUMABE"
],
"therapeuticClass": "N2C2 - ANTAGONISTAS DA CGRP ANTI-ENXAQUECA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1557300500026",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "N2C2",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:537520050009007"